Related Experiment Video

Updated: Oct 10, 2026

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

[Nebulized prostacyclin treatment for pulmonary hypertension in a 2-year-old girl]

R Puigarnau Vallhonrat1, M Pons Odena, E Carballo Ruano

  • 1Unitat Integrada Hospital Sant Joan de Déu-Hospital Clínic, Servicio de Pediatría, Sección de Cardiología, Universidad de Barcelona, Esplugues de Llobregat. Barcelona.

Anales Espanoles De Pediatria
|November 21, 2000
PubMed

Insights

Nebulized prostacyclin offered temporary clinical improvement for a child with primary pulmonary hypertension. This approach may be a useful alternative for non-responding pediatric patients.

Area of Science:

  • Pediatric Cardiology
  • Pulmonary Hypertension Research
  • Critical Care Medicine

Background:

  • Primary pulmonary hypertension is a rare childhood disease with unknown causes.
  • Standard treatments include diuretics, calcium-channel blockers, and intravenous prostacyclin for non-responders.
  • Diagnosis involves excluding secondary causes and confirming elevated pulmonary artery pressure.

Observation:

  • A 2-year-old child with right heart failure was diagnosed with primary pulmonary hypertension.
  • Initial stabilization included oxygen, fluid restriction, and diuretics.
  • Cardiac catheterization confirmed the diagnosis, with no positive pulmonary vascular reactivity.

Findings:

  • Nebulized prostacyclin was administered due to clinical deterioration.
  • The patient showed clinical improvement, with reduced oxygen and diuretic needs for 3 months.
  • Following this period, the patient's condition worsened, necessitating intravenous prostacyclin.

Implications:

  • Nebulized prostacyclin can be a beneficial alternative for pediatric patients with primary pulmonary hypertension who do not respond to conventional therapies.
  • This case highlights the potential utility of inhaled prostacyclin in managing severe pediatric pulmonary hypertension.
  • Further research is warranted to establish the long-term efficacy and safety of nebulized prostacyclin in this population.
Abstract

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...